Sugammadex for the reversal of rocuronium-induced neuromuscular blockade in surgical patients a review of clinical effectiveness
In patients undergoing surgery requiring general anesthesia, a neuromuscular blocking agent is often used to paralyze the vocal cords and facilitate intubation of the trachea and improve surgical conditions. At the conclusion of surgery, the NMB must be reversed, and depending on the depth of the NM...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
August 21, 2019, 2019
|
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | In patients undergoing surgery requiring general anesthesia, a neuromuscular blocking agent is often used to paralyze the vocal cords and facilitate intubation of the trachea and improve surgical conditions. At the conclusion of surgery, the NMB must be reversed, and depending on the depth of the NMB, the recovery may be spontaneous or a reversal agent can be administered. The purpose of this report is to synthesize and critically appraise the available evidence on the clinical effectiveness of sugammadex for rocuronium-induced NMB in patients undergoing surgery. This information may be used to inform decision making relating to health policy of the use of sugammadex |
|---|---|
| Physical Description: | 1 PDF file (39 pages) illustrations |